抑制TNFR/RIPK信号通路对神经细胞凋亡的影响及机制研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

陕西省自然科学基础研究计划项目(2014JM4139)


Effect and mechanism of neural cell apoptosis through regulating TNFR/RIPK signaling pathway
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 研究抑制TNFR/RIPK信号通路对急性脊髓损伤(ASCI)大鼠神经细胞凋亡的影响及作用机制。方法 160只雄性SD大鼠,随机分为空白对照组、假手术组、模型组、Nec1组,每组又根据时间点分为12h、24h、3d、7d四个亚组。采用动脉夹钳夹法制作ASCI模型,空白对照组不做任何处理,假手术组仅暴露脊髓,不损伤脊髓,模型组和Nec1组用动脉瘤夹脊髓全横截面1min,缝合伤口。空白对照组、假手术组和模型组注射给予生理盐水,Nec1组注射坏死性凋亡抑制剂Necrostain1(Nec1)溶液1μl/kg,1次/d,分别给药12h、24h、3d、7d。给药后以BBB评分对各组大鼠后肢神经功能恢复情况进行评分,完成评分后,取10只给药7d的大鼠脊髓,进行HE染色、Nissl染色、碘化丙啶(PI)染色、Tunel染色;另取10只给药7d的大鼠,取脊髓,用Western Blot检测RIP1、RIP3、Bcl2蛋白表达情况。结果 模型组和Nec1组各时间点的BBB评分均显著低于空白对照组和假手术组(P<005),Nec1组各时间点的BBB评分显著高于模型组(P<005)。造模7d后,模型组脊髓出现坏死、空洞现象,大量炎性细胞浸润,坏死区域面积显著高于假手术组(P<005);尼氏体呈细颗粒状,神经元数量减少、染色浅、排列无序,坏死性凋亡细胞较多;PI红染细胞、Tunel阳性细胞数、凋亡小体数量,以及RIPK1、RIPK3、Bcl2蛋白表达水平显著多于假手术组(P<005)。给予Nec1治疗7d后,Nec1组脊髓坏死组织较模型组少,空洞现象得到改善,炎性细胞浸润现象好转,Nec1组坏死区域面积显著低于空白对照组和假手术组(P<005);尼氏体着色的神经元细胞染色较深,颗粒变粗,存活神经元数量显著高于模型组(P<005);PI红染细胞数、凋亡小体数,以及RIPK1、RIPK3蛋白表达水平显著少于模型组(P<005),Bcl2蛋白表达水平显著高于模型组(P<005)。结论 坏死性凋亡抑制剂Nec1能通过抑制TNFR/RIPK信号通路,下调RIPK1、RIPK3、上调Bcl2的表达来缩小ASCI损伤面积,缓解炎症浸润,减少损伤周围神经元数量,改善神经元功能,提高损伤神经元及胶质细胞存活率,改善大鼠BBB评分,抑制坏死性凋亡。

    Abstract:

    【Abstract】 Objective To investigate the effect and mechanism of neural cell apoptosis of acute spinal cord injury (ASCI) rats through regulating TNFR/RIPK signaling pathway. Methods 160 male SD rats were randomly divided into blank control group, sham operation group, model group, and Nec1 group. Each group was divided into four subgroups according to time points: 12h, 24h, 3d, and 7d. The sham operation group (normal saline): spinal cord was exposed without injury. Model group (normal saline) and Nec1 group (1μl/kg Nec1): spinal cord was injured by artery clamp methods and the wound was sewn up. The blank control group received no treatment. The medication was once a day, and lasted for 12h, 24h, 3d, 7d respectively. After medication, the BBB score was performed. The spinal cord of 10 rats administered with 7d were used for HE staining, Nissl staining, propidium iodide (PI) staining, Tunel staining; Another spinal cord of 10 rats administered with 7d were used for the detection of RIP1, RIP3 and Bcl2 protein expression levels by Western Blot. Results The BBB score of three groups in a descending order was blank control group sham operation group, Nec1 group and model group (P<005). Neuronal manifestations of each group at the postmodeling 7d: the percentage of spinal cord necrosis, cavitation, massive inflammatory cell infiltration, and necrotic area of the model group was higher than that of the sham operation group and blank control group (P<005). The percentage of finegrained Nissl body, neurons of reduced, light staining and disordered, and increased necrotic apoptotic cells was high. The number of PI staining cells, Tunel positive cells, number of apoptotic bodies, and RIPK1, RIPK3 and Bcl2 protein expression in the model group were significantly higher than those in the sham operation group and blank control group (P<005). At the post 7d of Nec1medication, the above changes in the Nec1 group were ameliorated (P<005). The number of PIstained cells, the number of apoptotic bodies, and the expression levels of RIPK1 and RIPK3 proteins in the Nec1 group were significantly lower than those in the model group (P<005). The expression of Bcl2 protein in Nec1 group was significantly higher than that in the model group (P<005). Conclusion The necroptotic inhibitor Nec1 can inhibit necrotizing apoptosis by inhibiting TNFR/RIPK signaling pathway, which indicates to downregulate RIPK1, RIPK3, upregulate the expression of Bcl2, reduce inflammatory infiltration, reduce the number of peripheral neurons in injury, ameliorate the neuronal function, and improve the survival rate of damaged neurons and glial cells.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-06-27
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司